CRISPR-X Trademark
Trademark Overview
On Tuesday, October 31, 2023, a trademark application was filed for CRISPR-X with the United States Patent and Trademark Office. The USPTO has given the CRISPR-X trademark a serial number of 98247548. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, March 3, 2026. This trademark is owned by CRISPR Therapeutics AG. The CRISPR-X trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, t...
General Information
| Serial Number | 98247548 |
| Word Mark | CRISPR-X |
| Filing Date | Tuesday, October 31, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, March 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 7, 2025 |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the stylized wording "CRISPR-X", with the "X" being formed with curved edges ending in a point with three horizontal lines between the top two arms of the "X" and three horizontal lines between the bottom two arms of the "X". |
| Goods and Services | Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 8, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CRISPR Therapeutics AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 6300
CH |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 6300
CH |
Trademark Events
| Event Date | Event Description |
| Friday, November 3, 2023 | NEW APPLICATION ENTERED |
| Wednesday, November 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 9, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, May 1, 2024 | ASSIGNED TO EXAMINER |
| Thursday, May 9, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, May 9, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, May 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 8, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 10, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 1, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 7, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 7, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 4, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, August 20, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, August 20, 2025 | SOU EXTENSION 1 FILED |
| Wednesday, August 20, 2025 | SOU EXTENSION 1 GRANTED |
| Thursday, August 21, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 3, 2026 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 3, 2026 | SOU EXTENSION 2 FILED |
| Tuesday, March 3, 2026 | SOU EXTENSION 2 GRANTED |
| Wednesday, March 4, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 12, 2026 | TEAS STATEMENT OF USE RECEIVED |
